DFG underlines the need for long-term, knowledge-driven basic research

DFG underlines the need for long-term, knowledge-driven basic research

In view of the coronavirus pandemic, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has underlined the need for long-term, knowledge-driven basic research. Like all infectious diseases, the current coronavirus pandemic can be tackled all the more effectively the better we understand the pathogen and its effects on humans. This requires comprehensive long-term research, with the aim of understanding the genetic, biological, environmental, medical and socio-economic factors associated with an outbreak of this kind. Everything we currently know about the coronavirus, including diagnostic methods and possible treatment approaches, ultimately derives from the results of basic research." Professor Dr. Katja Becker, President of Germany's largest research funding organization Becker, who before taking office as DFG President in January was involved in malaria research in West Africa and elsewhere, also called for more intensive international cooperation. "Close communication between scientists, governments, the public and businesses, as well as a cooperative, coordinated approach between countries is essential. This is the only way for researchers and clinicians to efficiently share knowledge and learn from each other, and the only way to effectively limit the spread of the virus and its impacts on many areas of our lives. In the case of a pandemic like this, it is no longer about competition, whether in research or in other areas of society. It is about cooperation, anticipatory action, solidarity and ensuring protection for those who need it most." The DFG is already funding approximately 20 research projects and larger-scale research groups on coronaviruses and the infectivity and genetic diversity of viruses, with a total of around €18 million per year. Examples include CRC/Transregio (CRC/TRR) 84 "Innate Immunity of the Lung: Mechanisms of Pathogen Attack and Host Defence in Pneumonia", which is based in Berlin, Giessen and Marburg and has been funded since 2010, the Heidelberg-based CRC 1129 "Integrative Analysis of Pathogen Replication and Spread" and CRC 1021 "RNA Viruses: RNA Metabolism, Host Response and Pathogenesis" in Marburg, which have been funded since 2014 and 2013, respectively. Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More